In conclusion, our work underlines the necessity of the detection of the FLT3-ITD mutation in APL, that constitutes a separate entity of a worse prognosis and where new treatment strategies are necessary in order to decrease early mortality in an otherwise highly curable form of acute leukemia. Here, FLT3 is linked to acute promyelocytic leukemia.